The on-going deregulation process in Sweden has a major effect on market development and on Tamro’s performance, even though the main impact will not materialize until the financial year 2009/10. Uncertainty about the general economic development will slow down market growth in some of Tamro’s markets. However, for the remaining financial year Tamro expects the results to equal or exceed last year’s thanks to operational improvements and cost efficiency. Customers are at the heart of Tamro’s strategy, and Tamro’s measures to ensure even better customer loyalty will help Tamro to continue developing its position as a leading pharmaceutical wholesaler and retailer in Northern Europe.